Business Description
Qurient Co Ltd
ISIN : KR7115180002
Compare
Compare
Traded in other countries / regions
115180.Korea IPO Date
2016-02-29Description
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 48.11 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 19.31 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.6 | |||||
| 3-Year EPS without NRI Growth Rate | -4.5 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | -25.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.03 | |||||
| 9-Day RSI | 40.08 | |||||
| 14-Day RSI | 43.18 | |||||
| 6-1 Month Momentum % | 21.54 | |||||
| 12-1 Month Momentum % | -6.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.53 | |||||
| Quick Ratio | 19.48 | |||||
| Cash Ratio | 18.96 | |||||
| Days Inventory | 8.13 | |||||
| Days Sales Outstanding | 36.9 | |||||
| Days Payable | 2.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.9 | |||||
| Shareholder Yield % | -9.47 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.92 | |||||
| Operating Margin % | -275.73 | |||||
| Net Margin % | -251.18 | |||||
| FCF Margin % | -255.47 | |||||
| ROE % | -54.02 | |||||
| ROA % | -46.83 | |||||
| ROIC % | -251.69 | |||||
| ROC (Joel Greenblatt) % | -3350.59 | |||||
| ROCE % | -52.14 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.3 | |||||
| PB Ratio | 2.78 | |||||
| Price-to-Tangible-Book | 2.92 | |||||
| EV-to-EBIT | -4.13 | |||||
| EV-to-EBITDA | -4.29 | |||||
| EV-to-Revenue | 10.95 | |||||
| EV-to-FCF | -4.33 | |||||
| Price-to-Net-Current-Asset-Value | 3.33 | |||||
| Price-to-Net-Cash | 3.37 | |||||
| Earnings Yield (Greenblatt) % | -24.19 | |||||
| FCF Yield % | -16.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qurient Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 8,752.226 | ||
| EPS (TTM) (â‚©) | -746.96 | ||
| Beta | 0.57 | ||
| Volatility % | 49.26 | ||
| 14-Day RSI | 43.18 | ||
| 14-Day ATR (â‚©) | 225.996823 | ||
| 20-Day SMA (â‚©) | 4465.5 | ||
| 12-1 Month Momentum % | -6.17 | ||
| 52-Week Range (â‚©) | 3200 - 5860 | ||
| Shares Outstanding (Mil) | 32.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qurient Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qurient Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qurient Co Ltd Frequently Asked Questions
What is Qurient Co Ltd(XKRX:115180)'s stock price today?
The current price of XKRX:115180 is â‚©4285.00. The 52 week high of XKRX:115180 is â‚©5860.00 and 52 week low is â‚©3200.00.
When is next earnings date of Qurient Co Ltd(XKRX:115180)?
The next earnings date of Qurient Co Ltd(XKRX:115180) is .
Does Qurient Co Ltd(XKRX:115180) pay dividends? If so, how much?
Qurient Co Ltd(XKRX:115180) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers